PROFUSA, INC. Other Income Tax Expense (Benefit), Continuing Operations
PROFUSA, INC. (PFSA) reported Other Income Tax Expense (Benefit), Continuing Operations of $499.21 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-06.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherIncomeTaxExpenseBenefitContinuingOperations · last filed 2023-03-06
- PROFUSA, INC. other income tax expense (benefit), continuing operations for fiscal 2022 was $499.21K.
| Period end | Other Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|
| 2022-12-31 | $499.21K 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |